Rajini Chandrasegaram
Researcher Beacon
Seminars
Thursday 16th April 2026
The Evolving Neuroimmunology Drug Development Landscape
9:00 am
- From broad immunosuppression to precision neuroimmune modulation: Explore the surge in CNS‑penetrant agents and next‑generation mechanisms reshaping therapeutic strategies
- Pipeline and trial momentum: A high‑level view of leading assets and the most anticipated early‑phase readouts driving decision‑making
- Strategic moves shaping the field: Spotlight on recent deals, partnerships, and investment trends accelerating innovation in neuroimmune drug development
